Arey Secured Series A Funding for Hair Care Growth
The Los Angeles-based startup aims to expand its research and product lines after reporting positive findings in a recent clinical study.
Updated on Sept. 22, 2026 in Beauty
Live Poll
Do you trust that consumer hair care products can effectively reverse graying or aging hair?
Arey has secured Series A funding led by Unilever Ventures to support retail expansion and ongoing product development. The hair care company, which launched in 2021, focuses on products containing vitamins, antioxidants, and peptides.
Why it matters
The new capital will support the company's efforts to further clinical research and diversify its product offerings. This funding follows an earlier Series Seed round in 2023, signaling continued investment in the science behind pigment and hair health.
A randomized, double-blind, placebo-controlled trial published in the Journal of Drugs and Dermatology tracked the efficacy of Arey products. Findings showed 88 percent of participants had fewer or no new gray hairs, while 39 percent experienced repigmentation compared to the placebo group.
The players
Arey
A Los Angeles-based hair care company specializing in formulations with vitamins, antioxidants, and peptides.
Unilever Ventures
The venture capital arm of the global consumer goods company that focuses on investing in personal care and beauty technology.
Izzy Hemington
A principal at Unilever Ventures who joined the board of directors at Arey following the Series A investment.
Greycroft
A venture capital firm that participated in both the Series Seed and Series A funding rounds for the company.
Female Founders Fund
An early-stage venture fund focused on investing in companies led by female founders that contributed to the funding rounds.
The details
The brand's products utilize a combination of vitamins, antioxidants, and peptides designed to support hair follicle health and pigment production. By delivering these nutrients topically, the formulation aims to address the biological stressors that contribute to the graying process. Study participants reported that their hair was three times thicker, fuller, and shinier than the results observed in those using a placebo.
Timeline
2021: The Arey hair care company was launched.
2023: Arey secured its Series Seed funding round.
September 22, 2026: Series A funding was officially announced.
November 2026: Clinical trial results were published in the Journal of Drugs and Dermatology.
2028: The company plans to launch a new product extension line.
Health Landscape
This development reflects the growing trend of applying rigorous clinical standards to the beauty and personal care market. By publishing in the Journal of Drugs and Dermatology, the brand follows a pattern of using peer-reviewed methodology to substantiate claims of pigment maintenance.
If you are concerned about premature graying or thinning hair, monitor your scalp and hair health patterns over time to discuss with your dermatologist. It is worth asking your doctor about which specific hair care ingredients have established clinical evidence for your needs.
The takeaway
While clinical data suggests potential benefits for hair thickness and pigment, individual results can vary based on underlying biology. Consider tracking your hair care routine and discussing any changes in texture or graying with a dermatologist to determine if evidence-backed products fit your needs.
What happens next
The company expects to launch a new product extension line in 2028.
Further reading
For more information on the current state of cosmetic science and hair health research, visit the Beauty section.
Source note: This article includes information reported by WWD.
Live Poll
Do you trust that consumer hair care products can effectively reverse graying or aging hair?
